September 18th 2021, 12:00pm
Patients with rheumatoid arthritis (RA) who used tumor necrosis factor (TNF) inhibitors had significantly higher rates of nonmelanoma skin cancer and non-Hodgkin lymphoma.
September 15th 2021, 2:55pm
A new study lends insights into the prevalence of lung abnormalities in patients with newly diagnosed cases of rheumatoid arthritis (RA).
September 11th 2021, 7:30pm
In pediatric patients with frequently relapsing nephrotic syndrome (FRNS), the therapy was well tolerated, but did not lead to significant changes in disease course.
September 8th 2021, 3:10pm
The new study, based on an analysis of existing literature and a replication cohort, helps clarify the role of a variant in microRNA-146a.
September 1st 2021, 6:35pm
People who suffered trauma as a child appear to be at a higher risk of fibromyalgia, although it is unclear exactly why.
August 26th 2021, 1:00pm
German Hernandez, MD, FASN, FACP, and Ellen Ginzler, MD, MPH, discuss barriers to treatment access in lupus nephritis, and address future directions and unmet needs of the disease.
August 24th 2021, 6:51pm
Patients with axial spondyloarthritis waited the longest, according to new research.
August 24th 2021, 1:00pm
German Hernandez, MD, FASN, FACP, and Ellen Ginzler, MD, MPH, provide insight into the FDA approved therapies for lupus nephritis, belimumab and voclosporin, including an overview of clinical evidence, mechanism of action, and patient selection.
August 19th 2021, 1:00pm
Rheumatology and nephrology experts provide an overview of the pharmacologic treatment options in lupus nephritis and discuss recent FDA approved therapies belimumab and voclosporin.
August 17th 2021, 8:00pm
Results from the FUTURE 5 study show that more than 80% of patients had no radiographic progression of psoriatic arthritis, regardless of dose cohort or whether a loading dose was used.
